KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Petmed Express (PETS) Other Operating Expenses (2016 - 2025)

Historic Other Operating Expenses for Petmed Express (PETS) over the last 17 years, with Q4 2025 value amounting to $7.7 million.

  • Petmed Express' Other Operating Expenses rose 3340.81% to $7.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $58.7 million, marking a year-over-year increase of 8289.79%. This contributed to the annual value of $26.9 million for FY2025, which is 1738.28% down from last year.
  • According to the latest figures from Q4 2025, Petmed Express' Other Operating Expenses is $7.7 million, which was up 3340.81% from $6.6 million recorded in Q3 2025.
  • Petmed Express' 5-year Other Operating Expenses high stood at $35.6 million for Q2 2025, and its period low was $3.4 million during Q3 2021.
  • In the last 5 years, Petmed Express' Other Operating Expenses had a median value of $7.5 million in 2021 and averaged $8.3 million.
  • In the last 5 years, Petmed Express' Other Operating Expenses crashed by 3612.21% in 2024 and then surged by 26398.69% in 2025.
  • Petmed Express' Other Operating Expenses (Quarter) stood at $4.3 million in 2021, then skyrocketed by 39.25% to $6.0 million in 2022, then soared by 51.86% to $9.1 million in 2023, then crashed by 36.12% to $5.8 million in 2024, then surged by 33.41% to $7.7 million in 2025.
  • Its Other Operating Expenses was $7.7 million in Q4 2025, compared to $6.6 million in Q3 2025 and $35.6 million in Q2 2025.